3月8日(木)のつぶやき 11:54 from web usptoの1月版patent dashboadがリリースされました
Innovation is Costly, So Products, Market Access Rule Developments in the world of generics show larger companies buying me-too medicine providers to fill product pipelines and create new markets now not later. ジェネリック医薬品の世界での開発は、製品パイプラインを記入し、遅くとも今新たな市場を創造するために右にならえの薬のプロバイダを購入する大企業を示しています
Violations Are Cited in Generics Ranbaxy Laboratories, a maker of generic drugs, has run afoul of the Federal Drug Administration for violations at its United States factory in upstate New York. ランバクシーラボラトリーズ、ジェネリック医薬品のメーカー、米連邦医薬品局のニューヨーク州北部では、アメリカ合衆国工場出荷時に違。抵触しています
Teva Swallows Another Pill Maker Israeli pharmaceutical company agrees to buy German generics firm Ratiopharm in a deal valued at $5 billion. イスラエルの製薬会社の買収に50億ドルで評価され、ドイツのジェネリック医薬品会社Ratiopharmを購入することに同意する
Pfizer Profit Drops 19% On Generic Lipitor, Cuts Full-Year Forecast Pfizer said its first-quarter profit plunged on generic competition to its blockbuster cholesterol drug Lipitor. The world's largest drugmaker cut its full-year forecast after the sale of its nutrition business. ファイザー社はその最初の四半期の利益は、そのブロックバスターコレステロール薬リピトールのジェネリック医薬品との競争に急落した
Abbott Labs Joins Breakup Parade Abbott Laboratories has long been a one-stop healthcare conglomerate, with products ranging from major drugs it develops in house to branded generics, diagnostics and medical devices. That is changing, with the company announcing Wednesday it intends to split in two parts: a diversified medical products company and a slightly smaller pharmaceutical research & development business. アボットラボラトリーズ社は、長い間それがブランドのジェネリック医薬品、診断、および医療機器に社内で開発する主要な医薬品に至るまでの製品で、ワンストップの医療コングロマリットとなっています
FDA Clears New Blood Thinner Regulators approve Amphastar Pharmaceuticals-produced generic. レギュレータはAmphastarのジェネリック医薬品生産承認する
FDA Approves Watson Pharmaceuticals Generic Lovenox (Enoxaparin) The FDA has granted approval to Amphastar's generic version of Lovenox (enoxaparin sodium), Watson Pharmaceuticals has announced. The low molecular weight heparin will be sold by Watson under an arrangement with Amphastar. FDAがLovenoxのAmphastarのジェネリック版（エノキサパリンナトリウム）の承認を付与した、ワトソン医薬品は発表した
How Generics And ObamaCare Led To Express Scripts Mammoth Purchase Of Medco This morning, Express Scripts announced plans to buy rival Medco Health Solutions for $29 billion in cash and stock in a merger that will combine two of the largest managers of prescription drugs in the United States. It is the second-biggest deal of the year, after AT&T's proposed purchase of T-Mobile. The deal makes tremendous sense, because it will help the new, larger company weather what could be a difficult period in 2013 and 2014 when an influx of cheap, generic drugs could hurt its sales. 今朝、エクスプレススクリプトは、米国における処方薬の最大の経営者の2つを結合される合併の現金と株式で290億ドルのためにライバルメドコ健康ソリューションを購入する計画を発表した
What Amgen Faces in Brazil Better late than never. Pharma giant Amgen has finally discovered Brazil with its $215 million acquisition of generic and over-the-counter drug lab Bergamo Ltda on April 8. The deal allows Amgen to regain rights to its cancer drug Vectibix in Brazil. より遅いことも
Coupons for Patients, but Higher Bills for Insurers In their fight against generics, big pharmaceutical companies are covering part of patients’ co-payment for their drugs. But insurers say the practice raises the overall cost of care. ジェネリック医薬品との戦いでは、大手製薬企業が医薬品の患者の自己負担の一部をカバーしています
Generic drug maker gets FDA preliminary thumbs up US-based Handa Pharmaceuticals LLC has received the initial green light from the US Food and Drug Administration (FDA) to sell a generic version of the popular antipsychotic-medication Seroquel XR (quetiapine).
Fremont, California-based Handa said last week that its application to sell a generic version of AstraZeneca's Seroquel XR has been granted tentative approval by the US FDA.
Biopharmaceutical company AstraZeneca is headquartered in London.
The drug is also used to tre ... 米ベースの半田医薬品LLCは人気のある抗精神病薬投薬セロクエルXR（クエチアピン）のジェネリック版を販売する米国食品医薬品局（FDA）からの最初の緑色の光を受けています
Rite Aid's Reeling Sales Drugstore chain says generic drugs contribute to a drop in pharmacy performance. ドラッグストアチェーンのジェネリック医薬品は、薬局のパフォーマンスの低下に寄与するという
News Analysis: Losing Trust in Tylenol in the Wake of a Recall After a wide recall of children’s drugs, many parents are questioning the value, and sense of security, when buying a name brand over cheaper generic medicines. 子供の薬の広いリコールした後、多くの親は、値を聞いていると、セキュリティ、安いジェネリック医薬品以上のブランドを購入する感覚
